Search
for
Sort by
Research 30 of 743
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- Redefining hormone resistance in prostate cancer
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Editorial: Androgen-dependent diseases and their treatment
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- Endocrinology of the Aging Prostate: Current Concepts
- Highlights of This Issue
- Hormone Blocking Anticancer Drugs
- Therapeutic Strategies to Target the Androgen Receptor
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Doxetaxel: new indication. Prostate cancer: a few more weeks.
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Alternative androgen pathways
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels
- Is dehydroepiandrosterone a hormone?
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects